EN
HI
Bacil Pharma share price chart
Bacil Pharma Share Key Metrics
Volume
7526.00
Market Cap
12.87 CR
LTQ@LTP
35@21.85
ATP
21.85
Var Margin
25.95 %
Circuit Range
20.76-22.94
Delivery %
100 %
Value
1.64 L
ASM/GSM
No
Market Lot
1
Summary
BACPHAR stock price is ₹21.85 as of 2 Aug, 2026. The stock intraday movement has stayed between ₹21.85 and ₹21.85, while Bacil Pharma share price 52 week high low is ₹21.85 & ₹61.80.
In terms of trading activity, BACPHAR share price has recorded a volume of 7,526 shares. The Bacil Pharma has a market cap of ₹5890000. The stock’s Average Traded Price (ATP) stands at ₹21.85, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 35 @ ₹21.85.
The Bacil Pharma upper circuit limit is ₹22.94 & The Bacil Pharma lower circuit limit is ₹20.76, with a Value of ₹1.64 L. The Delivery Percentage for the day is 100%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bacil Pharma Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.5
Sector P/B
3.21
Sec. Div. Yield
0.52
Bacil Pharma Resistance and Support
Pivot 22.99
Resistance
First Resistance
22.99
Second Resistance
22.99
Third Resistance
22.99
Support
First Support
22.99
Second Support
22.99
Third Support
22.99
Bacil Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Jul 31 2026 | 21.85 | 21.85 | -4.92% | 21.85 | 21.85 |
| Thu Jul 30 2026 | 22.98 | 22.98 | -5.00% | 22.98 | 22.98 |
| Wed Jul 29 2026 | 24.19 | 24.19 | -4.95% | 24.19 | 24.19 |
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-09 | Others |
| 2026-06-26 | Fund Raising & Others |
| 2026-05-22 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
| 2025-01-21 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-10-15 | Others |
| 2024-09-27 | Increase in Authorised Capital |
| 2024-08-14 | Quarterly Results |
Bacil Pharma News
Bacil Pharma Ltd - 524516 - Announcement Under Regulation 30, LODR
Bacil Pharma has incorporated a wholly-owned subsidiary, Bacil Research & Development Private Limited, on July 28, 2026. This new entity is expected to drive the company's innovation and expansion into new business verticals within the healthcare sector.
Jul 28 2026 18:31:33
Bacil Pharma Ltd - 524516 - Attached Resignation Of Directors As Query Raised From BSE
Bacil Pharma's board approved a rights issue of equity shares to raise up to Rs. 50 crore. This significant fundraise also involved an increase in the company's authorized share capital to Rs. 65 crore, subject to shareholder approval.
Jul 18 2026 13:20:58
Read More
Bacil Pharma Management
| Name | Position |
|---|---|
| Dinesh Chander Notiyal | Non Executive Independent Director |
| Avani Savjibhai Godhaniya | Non Executive Independent Director |
Bacil Pharma Similar Stocks
Gujarat Terce Laboratories Ltd.
38.00
1.75 (4.83%)
GKB Ophthalmics Ltd.
58.00
2.47 (4.45%)
Tejnaksh Healthcare Ltd.
13.64
-0.08 (0.58%)
Gujarat Inject (Kerala) Ltd.
10.15
-0.05 (0.49%)
Cian Healthcare Ltd.
9.55
0.00 (0.00%)
Ishita Drugs & Industries Ltd.
75.27
0.00 (0.00%)
Emmessar Biotech & Nutrition Ltd.
25.34
0.48 (1.93%)
Kobo Biotech Ltd.
8.07
-0.16 (1.94%)
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 21.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 64.5 & 3.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 12.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 61.80 & 21.85. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
